{"organizations": [], "uuid": "d0dab1d09cade5a8e2cb2e8ed4419b2ba9617e82", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180328.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-us-fda-says-uscourt-files-permanen/brief-u-s-fda-says-u-s-court-files-permanent-injunction-against-mynicnaxs-llc-of-florida-idUSFWN1RA0NQ", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. FDA Says U.S.Court Files Permanent Injunction Against MyNicNaxs LLC Of Florida", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.942, "site_type": "news", "published": "2018-03-28T23:50:00.000+03:00", "replies_count": 0, "uuid": "d0dab1d09cade5a8e2cb2e8ed4419b2ba9617e82"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-us-fda-says-uscourt-files-permanen/brief-u-s-fda-says-u-s-court-files-permanent-injunction-against-mynicnaxs-llc-of-florida-idUSFWN1RA0NQ", "ord_in_thread": 0, "title": "BRIEF-U.S. FDA Says U.S.Court Files Permanent Injunction Against MyNicNaxs LLC Of Florida", "locations": [], "entities": {"persons": [{"name": "entere", "sentiment": "negative"}, {"name": "michael", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "deltona", "sentiment": "none"}, {"name": "florida", "sentiment": "none"}], "organizations": [{"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "fda says u.s.court files permanent injunction against mynicnaxs llc of florida", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 28 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FDA SAYS A U.S. DISTRICT COURT ENTERED A CONSENT DECREE OF PERMANENT INJUNCTION BETWEEN THE U.S. AND MYNICNAXS LLC OF DELTONA, FLORIDA\n* U.S. FDA SAYS THE U.S. DISTRICT COURT ALSO ENTERED THE CONSENT DECREE BETWEEN THE U.S. & MYNICNAXS’ OWNER CHEVONNE TORRES AND OFFICER MICHAEL BANNER\n* U.S. FDA - AS PER COMPLAINT FILED WITH CONSENT DECREE, FDA TESTS SHOWED SOME OF MYNICNAXS’ PRODUCTS CONTAINED UNDISCLOSED PHARMACEUTICAL INGREDIENTS\n* U.S. FDA - SOME OF THE UNDISCLOSED PHARMACEUTICAL INGREDIENTS THAT SHOWED IN MYNICNAXS’ PRODUCTS WERE SILDENAFIL, SIBUTRAMINE, AND PHENOLPHTHALEIN\n* U.S. FDA - PERMANENT INJUNCTION REQUIRES MYNICNAXS, DEFENDANTS TO CEASE DIRECTLY/INDIRECTLY DISTRIBUTING ANY UNAPPROVED NEW DRUGS OR MISBRANDED DRUGS Source text: ( bit.ly/2Gf9Uf1 )\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "http://bit.ly/2Gf9Uf1"], "published": "2018-03-28T23:50:00.000+03:00", "crawled": "2018-03-29T15:46:38.022+03:00", "highlightTitle": ""}